CTE Clinical Trials
Here are the 6 most popular medical studies for cte
Stem Cell Therapy
Stem Cell and Near Infrared Light Therapy for Alzheimer's Autism and Cognitive Impairment
“ Would like to help with a cure! I've only tried L-DOPA and I would like to try new medications and stem cell transplant.”
Belantamab Mafodotin for Multiple Myeloma
This trial is testing a new drug, belantamab mafodotin, as a possible treatment for multiple myeloma that has returned or does not respond to other treatments. The drug will be given as an IV on day 1 of each cycle, and the trial will last for 56 days.
Prednisone + Docetaxel + Apalutamide + Abiraterone Acetate + Atezolizumab + Niraparib for High Risk Localized Prostate Cancer
This trial will test whether a therapy based on the genomic testing of prostate tumour tissue will improve clinical response. Participants will be treated with LHRHa plus APA for 8 weeks while genome sequence characterization is done. Those with unevaluable tissue will remain on LHRHa plus APA for 16 weeks. Those with evaluable tissue will be assigned to one of three sub-studies and randomized to a specific treatment arm. The study will evaluate response rate and outcomes after radical prostatectomy.
NSCLC Clinical Trials
View 9 NSCLC medical studies.
TNO155 + Spartalizumab/Ribociclib for Colorectal Cancer
This trial is testing a new drug, TNO155, in combination with two other drugs, spartalizumab or ribociclib, to see if it is safe and effective in treating advanced solid tumors. The study will enroll subjects in two groups to compare the safety, tolerability, and preliminary effectiveness of the two combinations. Treatment will continue until the subject experiences unacceptable toxicity, disease progression, or treatment is discontinued at the discretion of the Investigator or the subject, or the subject withdraws consent.
DPX-Survivac + Cyclophosphamide + Pembrolizumab for Solid Tumors
This trial will test a new cancer treatment involving two drugs and immunotherapy. The goal is to see if it is safe and effective for treating certain types of advanced and recurrent solid tumors.
Combination Therapy for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertions
This trial will compare how effective amivantamab is at treating NSCLC with EGFR Exon 20ins mutations, compared to chemotherapy alone. The metric for success is progression-free survival (PFS).
Neuropathy Clinical Trials
View 8 Neuropathy medical studies.
Oral HIV Vaccine for HIV Infection
This trial will test a new oral HIV vaccine for safety and effectiveness. The vaccine uses a weakened form of Salmonella to deliver an HIV gene into the body, stimulating an immune response. The vaccine cannot cause HIV.
Phase 3 Cte Clinical Trials
View 99 phase 3 cte medical studies.
Fitusiran for Hemophilia
This trial is for hemophilia A or B sufferers to measure how well fitusiran treats bleeding episodes compared to the current standard of care. Participants will have phone & site visits every 2-8 weeks for 50 months. Home/remote visits may be allowed.
Tyrosine Kinase Inhibitor
Erdafitinib + Vinflunine/Docetaxel/Pembrolizumab for Bladder Cancer
This trial will compare the effectiveness of erdafitinib to chemotherapy or pembrolizumab in treating urothelial cancer that has progressed after 1-2 prior treatments.
Switching to DOR/ISL for HIV/AIDS
This trial will compare the safety and efficacy of switching to a new drug regimen (MK-8591A) versus continuing the current drug regimen (BIC/FTC/TAF) in HIV-1 infected individuals who are currently virally suppressed. The primary hypothesis is that the new drug regimen will be at least as effective as the current drug regimen in maintaining viral suppression.
Cte Clinical Trials With No Placebo
View 99 cte medical studies that do not have a placebo group.
Supportive Interventions for Infections
This trial is testing a multifaceted program to see if it can reduce surgical site infections (SSIs). The program includes improved basic perioperative preventive measures. The investigators aim to examine the relative effectiveness of each component of this program in controlling ESKAPE transmission and reducing SSIs and to identify an optimal implementation strategy for national dissemination.
View More Cte Trials
See another 65 many medical studies focused on cte.
Frequently Asked Questions
Introduction to cte
What are the top hospitals conducting cte research?
Chronic Traumatic Encephalopathy (CTE) is a complex neurodegenerative condition that has gained significant attention in recent years due to its association with repeated head injuries, particularly in contact sports. In the quest for understanding and finding effective treatments for CTE, top hospitals are leading the way in conducting clinical trials. Among these institutions is the esteemed Dana-Farber Cancer Institute based in Boston. With five ongoing CTE trials, they are at the forefront of research into this debilitating condition. Similarly, Memorial Sloan Kettering Cancer Center in New Yorkr Canchy (CTE) is a complex neurodegenerative condition that has gained significant attention in recent years due to its association with repeated head injuries, particularly in contact sports. In the quest for understanding and finding effective treatments for CTE, top hospitals are leading the way in conducting clinical trials. Among these institutions is the esteemed Dana-Farber Cancer Institute based in Boston. With five ongoing CTE trials, they are at the forefront of research into this debilitating condition. Similarly, Memorial Sloan Kettering Cancer Center in New York also prioritizes CTE research with an equal number of active trials aimed at unraveling the complexities surrounding this disorder.
Adding to these efforts is Tufts Medical Center, another renowned hospital located in Boston, where four active clinical trials focusing on CTE are currently underway. Not limited to just one region, two other notable locations involved in combating CTE through clinical research include a Research Site based out of New York and another situated in Montreal—each contributing three ongoing clinical trials dedicated to uncovering new insights about this challenging condition.
It's important to note that while these hospitals have made significant contributions by initiating several active studies related to CTE treatment and understanding; there hasn't been any recorded completed trial as yet highlighting how crucial it remains for further exploration into potential interventions or preventive measures against this progressive neurological disorder affecting individuals exposed to repetitive brain trauma.
The dedication shown by these institutions reflects their commitment not only toward alleviating the suffering caused by CTE but also fostering scientific progress that could reshape our approach towards preventing long-term consequences associated with traumatic brain injuries. By driving forward innovative research initiatives focused on improving our knowledge surrounding chronic traumatic encephalopathy, they offer hope for future generations impacted by head trauma and inspire collective efforts aimed at safeguarding athletes' well-being worldwide
Which are the best cities for cte clinical trials?
When it comes to clinical trials for chronic traumatic encephalopathy (CTE), several cities emerge as top contenders in research and development. New York, with 30 active trials, focuses on investigating treatments like Pembrolizumab and SRS, PF-07062119, among others. Los Angeles follows closely behind with 19 ongoing studies exploring interventions such as Durvalumab, Abemaciclib, and patients diagnosed with pulmonary arterial hypertension. New Yohy (CTE), several cities emerge as top contenders in research and development. New York, with 30 active trials, focuses on investigating treatments like Pembrolizumab and SRS, PF-07062119, among others. Los Angeles follows closely behind with 19 ongoing studies exploring interventions such as Durvalumab, Abemaciclib, and patients diagnosed with pulmonary arterial hypertension (PAH) or CTEPH. Atlanta boasts 17 active trials examining options like palliative radiation therapy, Maraviroc, ALIS, and more. Lastly, Chicago offers 16 active trials that delve into treatments including oral Cabotegravir (CAB), Durvalumab, Trastuzumab deruxtecan. Together these cities provide access to cutting-edge clinical trials for individuals battling CTE across the United States.
Which are the top treatments for cte being explored in clinical trials?
Clinical trials are actively exploring several promising treatments for Chronic Traumatic Encephalopathy (CTE). The top contenders in these trials include:
Treatment A: Currently being tested in X number of active CTE trials and Y number of all-time clinical trials.
Treatment B: Under investigation in Z number of ongoing CTE studies and W number of all-time clinical trials.
Treatment C: Showing potential with Q number of active CTE trials and R number of all-time clinical trials.
These innovative treatments offer hope for those affected by this debilitating condition, as researchers continue their relentless pursuit to find effective therapies for CTE.
What are the most recent clinical trials for cte?
Promising developments in clinical trials offer hope for those affected by chronic traumatic encephalopathy (CTE). One significant trial involves ASKG915, a potential treatment currently undergoing Phase 1 testing. Additionally, LB2102 is an experimental therapy showing promise in its Phase 1 trial for CTE patients. Immunotherapyn experimenthy (CTE). One significant trial involves ASKG915, a potential treatment currently undergoing Phase 1 testing. Additionally, LB2102 is an experimental therapy showing promise in its Phase 1 trial for CTE patients. Immunotherapy has also emerged as a potential avenue, with the combination of avelumab and lurbinectedin being evaluated during Phase 2 trials. The TAK-861 Dose 1 trial has advanced to both Phase 2 and Phase 3 stages, offering further possibilities for effective CTE treatments. These recent clinical trials provide optimism that innovative therapies will soon be available to improve the lives of individuals living with CTE.
What cte clinical trials were recently completed?
Recently completed clinical trials for chronic traumatic encephalopathy (CTE) are paving the way for enhanced understanding and potential treatments of this debilitating condition. Notably, a trial sponsored by Washington (CTE) are paving the way for enhanced understanding and potential treatments of this debilitating condition. Notably, a trial sponsored by Washington University School of Medicine was concluded in October 2021, focusing on addressing key aspects of CTE. The dedication to research is evident as scientists strive to unlock new insights into the complexities of CTE and develop strategies that could bring hope to individuals affected by this neurodegenerative disease.